FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to the isolated monoclonal antibody against TAU.
EFFECT: invention allows to effectively treat the diseases, which are associated with TAU.
11 cl, 50 dwg, 13 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPY AND DIAGNOSTICS BASED ON PROTEINS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER DISEASE | 2012 |
|
RU2645259C2 |
| ANTIBODIES, SPECIFIC TO HYPERPHOSPHORYLATED TAU-PROTEIN, AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2727911C2 |
| SUBSTANCES AND METHODS FOR USE IN THE PREVENTION AND/OR TREATMENT OF HUNTINGTON'S DISEASE | 2015 |
|
RU2742493C2 |
| ANTIBODIES SPECIFIC TO HYPERPHOSPHORYLATED TAU-PROTEIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2760875C1 |
| PROTOFIBRIL-BINDING ANTIBODIES AND USE THEREOF IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR PARKINSON'S DISEASE, DEMENTIA WITH LEWY BODIES AND OTHER ALPHA-SYNUCLEINOPATHIES | 2011 |
|
RU2555526C2 |
| METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND TIGIT INHIBITORS | 2014 |
|
RU2825390C2 |
| METHODS OF TREATING CANCER USING ANTAGONISTS BINDING TO PD-1 AXIS AND TIGIT INHIBITORS | 2014 |
|
RU2702108C2 |
| CRISPR/CAS SCREENING PLATFORM FOR IDENTIFICATION OF GENETIC MODIFIERS OF SEEDING OR AGGREGATION OF TAU PROTEIN | 2020 |
|
RU2819350C2 |
| HUMANISED ANTI-TAU ANTIBODIES | 2015 |
|
RU2743152C2 |
| PHOSPHO-SPECIFIC ANTIBODIES RECOGNIZING TAU | 2012 |
|
RU2639537C2 |
